Enabling doctors to treat skin diseases anytime, anywhere
With over 1,000,000 downloads, the Miiskin app has successfully connected with a vast patient base. Moreover, our website attracts over 100,000 monthly visitors, demonstrating the significant demand for online dermatology consultations.
Miiskin’s advanced digital dermatology platform provides 24/7 skin care for patients by dermatologists within our affiliated network. With our technology, we are shaping the future of digital skincare, catering to the increasing community of digital-first patients who seek on-demand access to high-quality care, regardless of time or location.
Two billion people are living with a challenging skin condition and one in four Americans seek medical care for a skin condition or concern every year. This is creating immense pressure on health systems. Patients are facing months-long waiting lists and rushed inefficient face-to-face visits; at the same time providers are struggling to keep up and many are on the brink of burnout.
Miiskin is changing that. Patients can now initiate efficient healthcare visits for skin problems or concerns directly from their smartphone with the Miiskin app. Real-life existence has shown that moving relatively simple dermatology visits online with Miiskin, and triaging patients to optimize face-to-face care delivery, reduces no-shows, cancellations rates and waiting lists while increasing provider time-efficiency by an estimated 20%. All through an asynchronous skin telehealth platform that is reimbursed by the largest private US health insurers, at the same level as in-person visits. Dermatology Clinics in the US and abroad are using this technology while also getting reimbursed at the same level as in-person visits.
The Miiskin app empowers patients to track their skin for changes, using the latest skin imaging technology. This has for example helped patients catch malignant skin changes and supports patients in managing complex chronic skin conditions such as acne, psoriasis and eczema.
Miiskin partners with leading skin health organizations, has won several innovation prizes, and has been widely covered by American and European media.
In 2015 Miiskin was founded by Jon Friis. His partner Rikke had multiple suspected malignant lesions removed. She needed to continuously check her moles for changes, which Miiskin now facilitates, as is the case for hundreds of thousands of other patients.
The Miiskin skin health solution is used by independent clinics, health systems and clinical research organizations for virtual care delivery and for remote monitoring purposes.
In 2015 the team set out to change digital skin health for the better. In the next few years the company’s trusted intelligent teledermatology and skin monitoring platform is expected to help millions of patients and their doctors.
Dr. Anna Chacon
MD, FAAD, Founder of Anna Chacon MD, private practice
Medical, surgical, and cosmetic dermatology; teledermatology
Ms. Indira Washingtong
Board-certified Physician Assistant Specialized in Dermatology
Medical and cosmetic dermatology and teledermatology
Medical Content Reviewers
Dr. Iben Marie Miller
Dermatology and Venereology
A/Prof. Patrick Mahar
Clinical Associate Professor
Adult and Paediatric Dermatology
Dr. Uffe Koppelhus
Dermatology and Biochemistry
Physician/Consultant Dermatologist at UCLH and CWH and Hon. Secretary of the British Skin Foundation
Skin cancer, Dermatology
Founder of DermnetNZ and Consultant Dermatologist at Waikato District Health Board, NZ
Melanoma, Dermatology, Teledermatology
MD and Medical Director
Dermatology and Mohs Surgery
Dr. Alpana Mohta
Pediatric and Aesthetic dermatology
Winner of EIC Investor Day with Euronext
Miiskin won the best Digital Health Platform.
Nominated for the Norrsken Award 2019
Miiskin was nominated for the Norrsken Award as one of the leading impact startups in all of Northern Europe.
Winner of the European Venture Contest 2018
The largest European venture contest with +2400 competing companies across 27 countries.
Awarded by European Union’s Horizon 2020
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 886422.
Miiskin approved on the NHS App Library
Miiskin is the first app of its kind to be approved on the NHS App Library (UK) and recommended by GP’s and other primary care clinicians in the UK on the EMIS App Library.
Read more here
It’s important to stay vigilant to changes in skin lesions. People should regularly examine their skin to become familiar with their usual moles, freckles, and other spots. It’s very useful to use photographs to keep a record of the skin’s appearance and this is facilitated by mobile apps. Changes to moles, such as changing shape or colour, growing in size, crusting, itching, bleeding, or the appearance of new moles or scaly spots, could be a warning sign of skin cancer. If in doubt, see your doctor.
Personal vigilance is important in monitoring the skin for new and changing moles. Many Dermatologists including myself have long advocated the use of photographic records for ongoing monitoring. This has become easier and cheaper with the widespread use of cameras and Apps (such as Miiskin) on personal phones, tablets and computers. New and changing moles, such as changing shape, size and colour and any crusting, itching or bleeding, are what to watch out for and report to your doctor.
The Miiskin app is a great way to encourage people to monitor their own skin regularly, to help track any changes which could be worrying. If any changes are noticed, the user can then visit their dermatologist for a medical assessment.